BioSpace News Archive

Deals

Sverica Capital Management Announces Acquisition of Gener8, LLC

Sverica Capital Management LP announced that it had acquired a majority interest in Gener8, LLC (“Gener8”). The investment marks Sverica’s sixth investment from its fourth fund.

August 21, 2018
·
2 min read
Business

John ‘Zeke’ Czekanski, Global Commercial Head, Leaves Fishawack

In consultation with John ‘Zeke’ Czekanski, Fishawack has mutually and amicably agreed that he will transition out of the business as we evolve our structure to accommodate the growth of the organization and recent acquisitions.

August 21, 2018
·
2 min read
Pharm Country

API Automation Accelerated with PilotFish’s New API XL Functionality

PilotFish announces its new novel API XL architecture which offers a simple means to encapsulate entire API-driven business processes. API XL supports the conversational integration that most published APIs require.

August 21, 2018
·
2 min read
Biotech Bay

IncellDx Launches BioINK PD-L1 CTC Core Kit with Lyophilized CTC Control Cells for Microfluidic Liquid Biopsies

IncellDx has launched a complete, pre-optimized kit to identify, enumerate, and quantify the important tumor therapeutic target PD-L1 on circulating tumor cells (CTCs).

August 21, 2018
·
2 min read
Business

Meditology Services and CloudPost Networks Introduce Healthcare’s First End-to-end Medical Device Security Solution

Meditology Services has partnered with CloudPost Networks to provide the industry’s first comprehensive end-to-end medical device security program solution.

August 21, 2018
·
2 min read
Biotech Beach

Ichor Medical Systems Announces Utilization of Its Investigational TriGrid Delivery System in a Clinical Trial Evaluating GX-188E Vaccine Combined with a Checkpoint Inhibitor for Treatment of Cervical Cancer

Ichor Medical Systems, Inc. (Ichor) announced today that its investigational TriGrid® Delivery System (TriGrid) is being utilized in a Phase 1b/2 clinical trial to administer GX-188E

August 21, 2018
·
4 min read
Deals

Renovia Completes $42.3 Million Series B Financing

Financing Will Accelerate Clinical Research, Development and New Digital Therapeutic Device Launches Targeted at Pelvic Floor Disorders

August 21, 2018
·
3 min read